Ticker: CO, Company: Global Cord Blood Corp, Type: 20-F, Date: 2020-07-29, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20200729/20-F/1/000.htm SEC Original: a20-15621_120f.htm
FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@globalcordbloodcorp.com 48 th Floor, Bank

---

---

Webplus: CO/20200729/20-F/2_EX-2.4/000.htm SEC Original: a20-15621_1ex2d4.htm
General As of the date of this annual report, our authorized share capital is US$25,100, consisting of 250,000,000 ordinary shares, par value US$0.0001 per share, and 1,000,000 shares of preferred stock, par value US$0.0001 per share, and the issued share capital consists of 121,551,075 ordinary shares fully paid or credited as fully paid. CCBS was incorporated as an exempted company

---

---

Webplus: CO/20200729/20-F/3_EX-12.1/000.htm SEC Original: a20-15621_1ex12d1.htm
Certification I, Ting Zheng, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 29, 2020 Ting Zheng Chief Executive Officer 1 EX-12.1 3 a20-15621_1ex12d1.htm EX-12.1

---

---

Webplus: CO/20200729/20-F/4_EX-12.2/000.htm SEC Original: a20-15621_1ex12d2.htm
Certification I, Albert Chen, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 29, 2020 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-12.2 4 a20-15621_1ex12d2.htm EX-12.2

---

---

Webplus: CO/20200729/20-F/5_EX-13.1/000.htm SEC Original: a20-15621_1ex13d1.htm
Certification GLOBAL CORD BLOOD CORPORATION July 29, 2020 Ting Zheng Chief Executive Officer July 29, 2020 Albert Chen Chief Financial Officer (Principal Financial Officer)

---

---

Webplus: CO/20200729/20-F/6_EX-15.1/000.htm SEC Original: a20-15621_1ex15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the Registration Statements (No. 333-183143 and No. 333-233880) on Form F-3 of Global Cord Blood Corporation of our reports dated Our report dated July 29, 2020, on the Beijing, China July EX-15.1 6 a20-15621_1ex15d1.htm EX-15.1

---

---

Webplus: CO/20200729/20-F/7_EX-15.2/000.htm SEC Original: a20-15621_1ex15d2.htm
通 商 律 師 事 務 所 Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel:(8610) 65693399 Fax: (8610) 65693838 Website: www.tongshang.com July 29 Global Cord Blood Corporation 48 th 1 Garden Road Central, Hong Kong S.A.R. Dear Sirs/Madams: Annual Report SEC We consent to the reference of our name under

---

Company Info:

Ticker: CO, Company: Global Cord Blood Corp, Type: 20-F, Date: 2020-07-29, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000